299 related articles for article (PubMed ID: 15155672)
1. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major.
Capul AA; Hickerson S; Barron T; Turco SJ; Beverley SM
Infect Immun; 2007 Sep; 75(9):4629-37. PubMed ID: 17606605
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.
Gaur U; Showalter M; Hickerson S; Dalvi R; Turco SJ; Wilson ME; Beverley SM
Exp Parasitol; 2009 Jul; 122(3):182-91. PubMed ID: 19328787
[TBL] [Abstract][Full Text] [Related]
4. Persistence without pathology in phosphoglycan-deficient Leishmania major.
Späth GF; Lye LF; Segawa H; Sacks DL; Turco SJ; Beverley SM
Science; 2003 Aug; 301(5637):1241-3. PubMed ID: 12947201
[TBL] [Abstract][Full Text] [Related]
5. Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.
Kébaïer C; Uzonna JE; Beverley SM; Scott P
Infect Immun; 2006 Jan; 74(1):777-80. PubMed ID: 16369039
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response.
Uzonna JE; Späth GF; Beverley SM; Scott P
J Immunol; 2004 Mar; 172(6):3793-7. PubMed ID: 15004184
[TBL] [Abstract][Full Text] [Related]
7.
Jesus-Santos FH; Lobo-Silva J; Ramos PIP; Descoteaux A; Lima JB; Borges VM; Farias LP
Front Cell Infect Microbiol; 2020; 10():408. PubMed ID: 32903718
[TBL] [Abstract][Full Text] [Related]
8. The role of phosphoglycans in Leishmania-sand fly interactions.
Sacks DL; Modi G; Rowton E; Späth G; Epstein L; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):406-11. PubMed ID: 10618431
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors.
Svárovská A; Ant TH; Seblová V; Jecná L; Beverley SM; Volf P
PLoS Negl Trop Dis; 2010 Jan; 4(1):e580. PubMed ID: 20084096
[TBL] [Abstract][Full Text] [Related]
10. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
[TBL] [Abstract][Full Text] [Related]
11. Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.
Favila MA; Geraci NS; Jayakumar A; Hickerson S; Mostrom J; Turco SJ; Beverley SM; McDowell MA
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004238. PubMed ID: 26630499
[TBL] [Abstract][Full Text] [Related]
12. An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.
Goyard S; Segawa H; Gordon J; Showalter M; Duncan R; Turco SJ; Beverley SM
Mol Biochem Parasitol; 2003 Aug; 130(1):31-42. PubMed ID: 14550894
[TBL] [Abstract][Full Text] [Related]
13. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters.
Ma D; Russell DG; Beverley SM; Turco SJ
J Biol Chem; 1997 Feb; 272(6):3799-805. PubMed ID: 9013638
[TBL] [Abstract][Full Text] [Related]
14. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana.
Ilg T
EMBO J; 2000 May; 19(9):1953-62. PubMed ID: 10790362
[TBL] [Abstract][Full Text] [Related]
15. Expanded Proteomic Survey of the Human Parasite Leishmania major Focusing on Changes in Null Mutants of the Golgi GDP-Mannose/Fucose/Arabinopyranose Transporter
Polanco G; Scott NE; Lye LF; Beverley SM
Microbiol Spectr; 2022 Dec; 10(6):e0305222. PubMed ID: 36394313
[TBL] [Abstract][Full Text] [Related]
16. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
17. Genetic differences between two Leishmania major-like strains revealed by suppression subtractive hybridization.
Wu ÂC; Freitas MA; Silva Sde O; Nogueira PM; Soares RP; Pesquero JB; Gomes MA; Pesquero JL; Melo MN
Mol Biochem Parasitol; 2015; 203(1-2):34-8. PubMed ID: 26542948
[TBL] [Abstract][Full Text] [Related]
18. Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.
Liu D; Kebaier C; Pakpour N; Capul AA; Beverley SM; Scott P; Uzonna JE
Infect Immun; 2009 Aug; 77(8):3272-83. PubMed ID: 19487470
[TBL] [Abstract][Full Text] [Related]
19. Golgi-located NTPDase1 of Leishmania major is required for lipophosphoglycan elongation and normal lesion development whereas secreted NTPDase2 is dispensable for virulence.
Sansom FM; Ralton JE; Sernee MF; Cohen AM; Hooker DJ; Hartland EL; Naderer T; McConville MJ
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3402. PubMed ID: 25521752
[TBL] [Abstract][Full Text] [Related]
20. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice.
Ilg T; Demar M; Harbecke D
J Biol Chem; 2001 Feb; 276(7):4988-97. PubMed ID: 11071892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
